Multiplicative Impact of Adverse Social Determinants of Health on Outcomes in Lupus Nephritis: A Meta‐analysis and Systematic Review

Documenti analoghi

• Clinical Significance of Therapeutic Drug Level Monitoring for Mycophenolate in Patients With Extrarenal Systemic Lupus Erythematosus—A Systematic Review and Meta‐Analysis
  di: Zahraa Qamhieh, et al.
  Pubblicazione: (2026)
• Addressing Economic Insecurities Can Improve Patient‐Reported Outcomes in Lupus
  di: Jay Patel, et al.
  Pubblicazione: (2026)
• Toward Optimal Dosing in Systemic Lupus Erythematosus: The Case for Hydroxychloroquine Blood Level Monitoring
  di: Stephen Balevic, et al.
  Pubblicazione: (2026)
• Development of the American College of Rheumatology Patient‐Reported Outcome Quality Measures for Systemic Lupus Erythematosus
  di: Patricia P. Katz, et al.
  Pubblicazione: (2024)
• Association Between 25‐hydroxyvitamin D Levels and Adverse Pregnancy Outcomes in Systemic Lupus Erythematosus
  di: Nima Madanchi, et al.
  Pubblicazione: (2024)